Arman Qamar: We are Routinely Evaluating VTE PRS in the Clinic in Many of Our Patients With Unprovoked VTE
Arman Qamar, Interventional Cardiologist NorthShore University HealthSystem, shared a post on LinkedIn:
“We are routinely evaluating VTE PRS in the clinic in many of our patients with unprovoked VTE. We discuss the evolving science in our recent review.”
Quoting RPTH Journal post:
“Recent studies demonstrate that polygenic risk score (PRS) significantly improves VTE risk prediction beyond traditional clinical factors. Recent findings indicate that PRS could inform thromboprophylaxis decisions for high-risk patients.”
Title: Role of polygenic risk scores in venous thromboembolism: current state and future directions
Authors: Aman Goyal, Sonia Hurjkaliani, Kevin Michael Alexander, Jianfeng Xu, Manan Pareek, Arman Qamar
Read full article here.
Stay updated with Hemostasis Today.
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
-
Jun 6, 2026, 07:59Razan Awan: Large Cohort Study Questions Routine Use of Dual Antiplatelet Therapy After TAVI
-
Jun 6, 2026, 07:28Ahmed Dheyaa Al-Obaidi: Retrospective Study Highlights the Role of Transient Elastography in Pediatric Hepatic Fibrosis
-
Jun 6, 2026, 06:55Valeria Galetti: Understanding the Root Causes of Anemia in Madagascar
-
Jun 6, 2026, 06:45Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP
-
Jun 6, 2026, 06:20Pedro Gaspar: The Role of CD4⁺ T Cells in APS